Parexel and ASAN accelerate Korea-based drug development
CRO Parexel International has joined with ASAN Medical Center (AMC), based in Seoul, Korea, to offer clinical trial sponsors based regionally and internationally access to clinical trial services throughout Asia, with a focus on early phase development.
“With ASAN Medical Center's leadership in clinical trials, in-depth expertise, state-of-the art facilities and a renowned network of hospitals, we believe our alliance will offer unique advantages to the Korean biopharmaceutical industry,” said Mark A. Goldberg, M.D., COO of Parexel. “We look forward to contributing to continued drug development growth in the region through shared learnings, technologies and best practices."
The AMC Clinical Trial Center, which opened in 2002, was designated as the Regional Clinical Trial Center by the Korean Ministry for Health, Welfare and Family Affairs in 2006. The government's investment made it possible for the center to rapidly build infrastructure.